Nevertheless, as a consequence of the diverse and contradictory information surrounding patient survival when analyzing both primary and metastatic melanomas, the prognostic value of BRAF mutations is still under discussion [25,36,37,38,39,40,41]. The gene discussed is BRAF; the disease is metastatic melanoma.